Medvolt
The AI engine Fit Assessment
BetaMedvolt effectively leverages machine learning to discover patterns and expand therapeutics, including drug repurposing capabilities.
Blurb
Medvolt is an AI platform for drug discovery and repurposing.
HQ Location
India
Founded
2021
Employees
1 - 10
Total funding raised
Not available
Last Funding Event
Not available
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
- Drug Repurposing
Developer of biomedical research platform designed to accelerate life sciences research. The company focuses on accelerating drug discovery and development by democratizing access to AI-powered technology and clean data by leveraging a highly modular and data-driven, thereby reducing costs and increasing the probability of success.